figshare
Browse
ppat.1009594.s010.docx (23.84 kB)

Subject demographic characteristics.

Download (23.84 kB)
journal contribution
posted on 2021-05-28, 17:44 authored by Sean C. Murphy, Gregory A. Deye, B. Kim Lee Sim, Shirley Galbiati, Jessie K. Kennedy, Kristen W. Cohen, Sumana Chakravarty, Natasha KC, Yonas Abebe, Eric R. James, James G. Kublin, Stephen L. Hoffman, Thomas L. Richie, Lisa A. Jackson

(DOCX)

History

Usage metrics

    PLOS Pathogens

    Categories

    Keywords

    malaria increases5.12 x 10 4 PfSPZ-CVacCHMI groupsmalaria infectionblood-stage parasitemiadose escalation trialdose group1.024 x 10 5 PfSPZ-CVacVE warrantvenous inoculationserythrocyte stage parasitemiastudy groupplacebo-controlled trialantimalarial chemoprophylaxisvaccine administrationPfSPZ-CVac efficacyvaccinationDVI 10 weeksgroups proceedinginterval groupClinical trials registrationPlasmodium falciparum sporozoites10 weeksmalaria infection PfSPZ-CVacpreviously-published PfSPZ-CVac study28 daysNCT 02773979

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC